[CYCC] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
16-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 47.16%
YoY- 45.14%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 715 735 309 38 164 159 230 20.79%
PBT -3,187 -5,661 -5,746 -3,572 -3,571 -3,950 -3,329 -0.72%
Tax -478 -750 -730 -419 -126 -143 -205 15.14%
NP -2,709 -4,907 -5,004 -1,890 -3,445 -3,807 -3,124 -2.34%
Tax Rate - - - - - - - -
Total Cost 3,424 5,642 5,313 1,928 3,609 3,966 3,354 0.34%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -378.88 -667.62 -1,619.42 -4,973.68 -2,100.61 -2,394.34 -1,358.26 -19.15%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -18.75 -51.93 -67.51 -53.81 -107.75 -172.72 -226.51 -33.97%
EPS Diluted -18.75 -51.93 -67.51 -53.81 -107.75 -172.72 -226.51 -33.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.